Results 21 to 30 of about 1,027,648 (153)
Utility of venoactive compounds in post-thrombotic syndrome: A systematic review. [PDF]
J Vasc Surg Venous Lymphat DisordGloviczki ML +4 more
europepmc +2 more sources
Evidence-Based Complementary and Alternative Medicine, Volume 2022, Issue 1, 2022., 2022 Neurodegeneration is the final event after a cascade of pathogenic mechanisms in several brain disorders that lead to cognitive and neurological loss. Quinolinic acid (QA) is an excitotoxin derived from the tryptophan metabolism pathway and is implicated in several ailments, such as Alzheimer’s, Parkinson’s, Huntington’s, and psychosis disease. Diosmin
Mian Huang +6 more
wiley +1 more source
Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue 4, May 2021., 2021 Abstract Introduction Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking. Micronized purified flavonoid fraction (MPFF) is a venoactive drug used in the treatment of CVI.
Ke Xuan Li +4 more
wiley +1 more source
Фармация и фармакология (Пятигорск), 2021 Micronized purified flavonoid fraction (MPFF) is the original phlebotropic drug. Its marketed form (Detralex®) consists of 90% diosmin and 10% of other flavonoids. Calculated as hesperidin, it is the most widely used drug today.
E. F. Stepanova +4 more
doaj +1 more source
Current principles of symptomatic treatment of lymphovenous insufficiency
Амбулаторная хирургия, 2023 This article provides a review of the current literature on the current principles of symptomatic treatment of lymphovenous insufficiency. Lymphovenous insufficiency is an urgent problem of modern phlebology, the prevalence of this pathology reaches 50 ...
S. S. Dunaevskaya
doaj +1 more source
RETRACTED: Pathogenetic substantiation of phlebotropic therapy for chronic venous diseases
Амбулаторная хирургия, 2019 RETRACTED ARTICLEChronic venous disease (CVD) is the most common vascular pathology that has a significant negative effect on physical and psychological health outcomes, and requires high level of public spending on healthcare. Number of CVD risk factors
V. Yu. Bogachev +4 more
doaj +1 more source
Pharmacotherapy of chronic venous insufficiency of the lower extremities
Амбулаторная хирургия, 2018 Chronic venous insufficiency (CVI) is the most common pathology of the peripheral vascular system. One of the main principles of conservative treatment for both small and complicated forms is pharmacotherapy with the use of venoactive drugs.
O. V. Dzhenina +2 more
doaj +1 more source
Research and Practice in Thrombosis and Haemostasis, Volume 4, Issue 5, Page 714-721, July 2020., 2020 Abstract Venous thromboembolism (VTE) is a major cause of morbidity and mortality. The impact of the Surgeon General’s Call to Action in 2008 has been lower than expected given the public health impact of this disease. This scientific statement highlights future research priorities in VTE, developed by experts and a crowdsourcing survey across 16 ...
Mary Cushman +15 more
wiley +1 more source
Journal of Gastroenterology and Hepatology, Volume 35, Issue 4, Page 577-585, April 2020., 2020 Abstract Background and Aim The CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research) was conducted to provide data on patients presenting with hemorrhoidal disease (HD) in clinical practice and to explore the frequency with which it coexists with chronic venous disease (CVD) and shared risk factors.
Philippe Godeberge +6 more
wiley +1 more source